BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 25560998)

  • 1. Characterization of equine urinary metabolites of selective androgen receptor modulators (SARMs) S1, S4 and S22 for doping control purposes.
    Hansson A; Knych H; Stanley S; Thevis M; Bondesson U; Hedeland M
    Drug Test Anal; 2015 Aug; 7(8):673-83. PubMed ID: 25560998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of the selective androgen receptor modulators S1, S4 and S22 and their metabolites in equine plasma using high-resolution mass spectrometry.
    Hansson A; Knych H; Stanley S; Thevis M; Bondesson U; Hedeland M
    Rapid Commun Mass Spectrom; 2016 Apr; 30(7):833-42. PubMed ID: 26969924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARM-S4 and metabolites detection in sports drug testing: a case report.
    Grata E; Perrenoud L; Saugy M; Baume N
    Forensic Sci Int; 2011 Dec; 213(1-3):104-8. PubMed ID: 21816554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The fungus Cunninghamella elegans can produce human and equine metabolites of selective androgen receptor modulators (SARMs).
    Rydevik A; Thevis M; Krug O; Bondesson U; Hedeland M
    Xenobiotica; 2013 May; 43(5):409-20. PubMed ID: 23153056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator andarine (S-4) for routine doping control purposes.
    Thevis M; Thomas A; Fusshöller G; Beuck S; Geyer H; Schänzer W
    Rapid Commun Mass Spectrom; 2010 Aug; 24(15):2245-54. PubMed ID: 20623476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator S-22 to identify potential targets for routine doping controls.
    Thevis M; Thomas A; Möller I; Geyer H; Dalton JT; Schänzer W
    Rapid Commun Mass Spectrom; 2011 Aug; 25(15):2187-95. PubMed ID: 21710598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural elucidation of major selective androgen receptor modulator (SARM) metabolites for doping control.
    Garg N; Hansson A; Knych HK; Stanley SD; Thevis M; Bondesson U; Hedeland M; Globisch D
    Org Biomol Chem; 2018 Jan; 16(5):698-702. PubMed ID: 29319101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquid chromatography-high resolution/ high accuracy (tandem) mass spectrometry-based identification of in vivo generated metabolites of the selective androgen receptor modulator ACP-105 for doping control purposes.
    Thevis M; Thomas A; Piper T; Krug O; Delahaut P; Schänzer W
    Eur J Mass Spectrom (Chichester); 2014; 20(1):73-83. PubMed ID: 24881457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro metabolism studies on the selective androgen receptor modulator (SARM) LG121071 and its implementation into human doping controls using liquid chromatography-mass spectrometry.
    Knoop A; Krug O; Vincenti M; Schänzer W; Thevis M
    Eur J Mass Spectrom (Chichester); 2015; 21(1):27-36. PubMed ID: 25906032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-depth metabolic study of nonsteroidal selective androgen receptor modulator GSK2881078 in thoroughbred horses and horse liver microsomes for doping control.
    Karatt TK; Sathiq MA; Laya S; Kal AKK; Subhahar MB; Muhammed Ajeebsanu MP; Philip M; Caveney MR; Graiban FM
    Drug Test Anal; 2023 Jul; 15(7):757-768. PubMed ID: 36922727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and Synthesis of Selected In Vitro Generated Metabolites of the Novel Selective Androgen Receptor Modulator (SARM) 2f.
    Möller T; Wen HC; Naumann N; Krug O; Thevis M
    Molecules; 2023 Jul; 28(14):. PubMed ID: 37513414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of in vitro generated metabolites of the selective androgen receptor modulators S-22 and S-23 and in vivo comparison to post-administration canine urine specimens.
    Thevis M; Gerace E; Thomas A; Beuck S; Geyer H; Schlörer N; Kearbey JD; Dalton JT; Schänzer W
    Drug Test Anal; 2010; 2(11-12):589-98. PubMed ID: 20967890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of equine in vitro metabolites of seven non-steroidal selective androgen receptor modulators for doping control purposes.
    Cutler C; Viljanto M; Taylor P; Hincks P; Biddle S; Van Eenoo P
    Drug Test Anal; 2022 Feb; 14(2):349-370. PubMed ID: 34714606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of the metabolism of the selective androgen receptor modulator LGD-4033 in equine urine, plasma and hair following oral administration.
    Cutler C; Viljanto M; Hincks P; Habershon-Butcher J; Muir T; Biddle S
    Drug Test Anal; 2020 Feb; 12(2):247-260. PubMed ID: 31655494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of the arylpropionamide-derived selective androgen receptor modulator (SARM) S-4 (Andarine) in a black-market product.
    Thevis M; Geyer H; Kamber M; Schänzer W
    Drug Test Anal; 2009 Aug; 1(8):387-92. PubMed ID: 20355219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro metabolism study of a black market product containing SARM LGD-4033.
    Geldof L; Pozo OJ; Lootens L; Morthier W; Van Eenoo P; Deventer K
    Drug Test Anal; 2017 Feb; 9(2):168-178. PubMed ID: 26767942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanding sports drug testing assays: mass spectrometric characterization of the selective androgen receptor modulator drug candidates RAD140 and ACP-105.
    Thevis M; Piper T; Beuck S; Geyer H; Schänzer W
    Rapid Commun Mass Spectrom; 2013 Jun; 27(11):1173-82. PubMed ID: 23650030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Equine in vivo-derived metabolites of the SARM LGD-4033 and comparison with human and fungal metabolites.
    Hansson A; Knych H; Stanley S; Berndtson E; Jackson L; Bondesson U; Thevis M; Hedeland M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Feb; 1074-1075():91-98. PubMed ID: 29334634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic study of selective androgen receptor modulator LY2452473 in thoroughbred horses for doping control.
    Karatt TK; Sathiq MA; Laya S; Karakka Kal AK; Subhahar MB; M P MA; Philip M; Graiban FM; Caveney MR
    Rapid Commun Mass Spectrom; 2023 May; 37(9):e9491. PubMed ID: 36758220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The forensic response after an adverse analytical finding (doping) involving a selective androgen receptor modulator (SARM) in human athlete.
    Kintz P
    J Pharm Biomed Anal; 2022 Jan; 207():114433. PubMed ID: 34715583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.